VIVEbiotech heads to Advanced Therapies Europe
The company will be in Barcelona to connect with customers, partners and professionals from the advanced therapies sector.
VIVEbiotech will participate in Advanced Therapies Europe, taking place in Barcelona from September 7 to 9. The event will bring together leading stakeholders from the advanced therapies ecosystem and provide an excellent opportunity to exchange knowledge, strengthen relationships and explore new collaboration opportunities.
As a Bronze Sponsor, VIVEbiotech will be present at booth #56, where team members will be available to discuss the latest developments in lentiviral vector manufacturing and the evolving needs of advanced therapy developers.
In addition, on September 9, from 1:30 to 2:30 p.m., Patricio Massera will moderate the panel From Early Development to Commercial Readiness: Real-World Lessons in Advancing Lentiviral-Based Therapies.
Join VIVEbiotech, Kiji Therapeutics and Genewity for an interactive panel exploring how lentiviral vector-based therapies are advancing across the full development pathway, from early-stage innovation to clinical and commercial readiness.
The discussion will address key topics including vector design, process development, GMP manufacturing scale-up, and how early strategic decisions can support successful regulatory and commercialization outcomes.
Advanced Therapies Europe will be the first of a series of industry conferences and events in which VIVEbiotech will participate over the coming months, providing new opportunities to strengthen existing relationships, establish new connections and contribute to the conversations shaping the future of cell and gene therapies.